Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases

被引：23
|
作者：
Theodosiou, Zenonas
Kasampalidis, Ioannis N.
Karayannopoulou, Georgia [2 ]
Kostopoulos, Ioannis [2 ]
Bobos, Mattheos [2 ]
Bevilacqua, Generoso [3 ,4 ]
Aretini, Paolo [5 ]
Starita, Antonina [6 ]
Lyroudia, Kleoniki [7 ]
Pitas, Ioannis [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Informat, Artificial Intelligence & Informat Anal Lab, Thessaloniki 54124, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, Thessaloniki 54124, Greece
[3] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastruct Pathol, I-56126 Pisa, Italy
[4] Pisa Univ Hosp, I-56126 Pisa, Italy
[5] Inst Mol Genet & Med, MGM, I-56126 Pisa, Italy
[6] Univ Pisa, Dept Informat, I-56127 Pisa, Italy
[7] Aristotle Univ Thessaloniki, Sch Dent, Dept Endodontol, Thessaloniki 54124, Greece
来源：
BREAST | 2008年 / 17卷 / 01期
关键词：
HER2; fluorescence in situ hybridization (FISH); automated image analysis;
D O I：
10.1016/j.breast.2007.07.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HER2-positive breast cancer is characterized by aggressive growth and poor prognosis. Women with metastatic breast cancer with over-expression of HER2 protein or excessive presence of HER2 gene copies are potential candidates for Herceptin (Trastuzumab) targeted treatment that binds to HER2 receptors on tumor cells and inhibits tumor cell growth. Fluorescence in situ hybridization (FISH) is one of the most widely used methods to determine HER2 status. Typically, evaluation of FISH images involves manual counting of FISH signals in multiple images, a time consuming and error prone procedure. Recently, we developed novel software for the automated evaluation of FISH images and, in this study, we present the first testing of this software on images from two separate research clinics. To our knowledge, this is the first concurrent evaluation of any FISH image analysis software in two different clinics. The evaluation shows that the developed FISH image analysis software can accelerate evaluation of HER2 status in most breast cancer cases. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [31] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 173 - 173
  • [32] Her2/neu FISH amplification in negative immunohistochemistry scored breast carcinomas
    Dayan, SA
    Silverman, JF
    Liu, YL
    Smith, CA
    Shackney, SE
    MODERN PATHOLOGY, 2005, 18 : 31A - 31A
  • [33] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Agersborg, Sally
    Mixon, Christopher
    Thanh Nguyen
    Aithal, Sramila
    Blocker, Forrest
    Weiss, Lawrence
    Gasparini, Robert
    Jiang, Shiping
    Chen, Wayne
    Hess, Gregory
    Albitar, Maher
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Sally Agersborg
    Christopher Mixon
    Thanh Nguyen
    Sramila Aithal
    Sucha Sudarsanam
    Forrest Blocker
    Lawrence Weiss
    Robert Gasparini
    Shiping Jiang
    Wayne Chen
    Gregory Hess
    Maher Albitar
    Breast Cancer Research and Treatment, 2018, 170 : 321 - 328
  • [35] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Agersborg, Sally
    Mixon, Christopher
    Thanh Nguyen
    Aithal, Sramila
    Sudarsanam, Sucha
    Blocker, Forrest
    Weiss, Lawrence
    Gasparini, Robert
    Jiang, Shiping
    Chen, Wayne
    Hess, Gregory
    Albitar, Maher
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 321 - 328
  • [36] Her2/neu FISH amplification in negative immunohistochemistry scored breast carcinomas
    Dayan, SA
    Silverman, JF
    Liu, YL
    Smith, CA
    Shackney, SE
    LABORATORY INVESTIGATION, 2005, 85 : 31A - 31A
  • [37] Evaluation of HER2 expression and amplification on CTCs using DEPArray analysis and sorting followed by FISH
    Brouwer, A.
    Verhoest, F.
    Vermeulen, P.
    Rutten, A.
    Prove, A.
    Van Laere, S.
    Peeters, M.
    Dirix, L.
    CANCER RESEARCH, 2017, 77
  • [38] Multiplex Ligation-Dependent Probe Amplification (MLPA) Compared to Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) for Assessing HER2 Amplification in Invasive Breast Carcinoma
    Elavathil, L.
    Manan, A.
    Moreno, J.
    Carter, R.
    Connie, L.
    Savola, S.
    Lytwyn, A.
    LABORATORY INVESTIGATION, 2012, 92 : 36A - 37A
  • [39] Multiplex Ligation-Dependent Probe Amplification (MLPA) Compared to Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) for Assessing HER2 Amplification in Invasive Breast Carcinoma
    Elavathil, L.
    Manan, A.
    Moreno, J.
    Carter, R.
    Connie, L.
    Savola, S.
    Lytwyn, A.
    MODERN PATHOLOGY, 2012, 25 : 36A - 37A
  • [40] Utility of cytopathological specimens and an automated image analysis for the evaluation of HER2 status and intratumor heterogeneity in breast carcinoma
    Arihiro, Koji
    Oda, Miyo
    Ogawa, Katsunari
    Kaneko, Yoshie
    Shimizu, Tomomi
    Tanaka, Yuna
    Marubashi, Yukari
    Ishida, Katsunari
    Takai, Chikako
    Taoka, Chie
    Kimura, Shuji
    Shiroma, Noriyuki
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (12) : 1126 - 1132
12345